scholarly journals Acquisitions And Common Stock Returns In The Health Care Industry: 1982-1985

2011 ◽  
Vol 5 (1) ◽  
pp. 59 ◽  
Author(s):  
Rose Rubin ◽  
Imre Karafaith ◽  
Kenneth L. Smith

Employing a methodology commonly used to determine the movement of stock returns around a specific event, we examined the movement of common stock returns of acquiring firms in the health care industry for three periods, 1982-1983, 1984, and 1985. We find that in the 1982-1983 period, investors could expect negative excess returns from holding tock in acquiring firms in the health care industry. In contrast, for the 1984 and 1985 periods we find no evidence of excel returns for investors. The difference between the two periods, we believe, is due to the more competitive environment which existed in the industry in the latter two periods.

2011 ◽  
pp. 219-238 ◽  
Author(s):  
Pooja Deshmukh ◽  
David Croasdell

This chapter explores privacy and security issues in health care. It describes the difference between privacy and security in the context of health care, identifies sources of concern for individuals who use information technologies for health-related purposes, and presents technology-based solutions for privacy and security in health care networks. The purpose of the chapter is to provide an investigation of the sources of concern for regulations and technologies in the health care industry. The discussion is based on the Health Insurance Portability and Accountability Act (HIPAA) and its eight guiding principles. The chapter explores the implications of legal and regulatory environments driving HIPAA regulations, the need for privacy and security in health care networks, and information technologies used in the health care industry. Related ethical issues, current technologies for providing secure solutions that comply with the regulations, and products emerging in the market are also examined.


2011 ◽  
pp. 1897-1909
Author(s):  
Pooja Deshmukh ◽  
David Croasdell

This chapter explores privacy and security issues in health care. It describes the difference between privacy and security in the context of health care, identifies sources of concern for individuals who use information technologies for health-related purposes, and presents technology-based solutions for privacy and security in health care networks. The purpose of the chapter is to provide an investigation of the sources of concern for regulations and technologies in the health care industry. The discussion is based on the Health Insurance Portability and Accountability Act (HIPAA) and its eight guiding principles. The chapter explores the implications of legal and regulatory environments driving HIPAA regulations, the need for privacy and security in health care networks, and information technologies used in the health care industry. Related ethical issues, current technologies for providing secure solutions that comply with the regulations, and products emerging in the market are also examined.


Author(s):  
Afua Agyekum ◽  
Sharon Finney ◽  
Ayishat Omar ◽  
Alex P Tang

The 2016 presidential election had important implications for the country’s health care policies. In this study, we examine the health care industry stock returns associated with the 2016 presidential campaign. We use both market model and seemingly unrelated regression (SUR) methodologies to estimate abnormal stock returns of each health care sector associated with each event. Our results are robust and mostly consistent with our arguments. The regression analysis further augments our event study results. We find that, during the pre-election period, the Biological Products, Health Insurance, and Major Pharmaceuticals all suffer significantly negative cumulative average abnormal returns (CAARs). The Hospital/Nursing Management and Medical/Dental Instruments fare reasonably well. Our interpretation is that the market takes a dim view on the Biological Products, Health Insurance, and Major Pharmaceuticals sectors when the consensus is that Clinton would win the election. When the election is over, the fortune reverses for the Biological Products and Major Pharmaceuticals. It continues when President Trump meets with the health care industry CEOs. The regression results further confirm our event study results. Our study shows that the 2016 election has a significant impact on the affected industry and the firms in the industry. However, even in the same broad industry, sectors/firms fare differently. Our study shows that it is important to identify the winning and losing sectors and examine the impact of an election on various sectors in a detailed and refined way.


2015 ◽  
Vol 41 (10) ◽  
pp. 1059-1076 ◽  
Author(s):  
Jeffery Scott Bredthauer ◽  
Brian C. Payne ◽  
Jiri Tresl ◽  
Gordon V. Karels

Purpose – The purpose of this paper is to investigate the absolute and risk-adjusted stock return performance of the US health care industry conditional upon the presidential administration’s political party and the Federal Reserve’s monetary policy stance. It evaluates this return behavior across the 60-year time period from 1954 to 2013, and sub-divides this entire period into the pre-Medicare period (1954-1964), Medicare period (1965-1984), and Medicare-plus-high-health-care-inflation period (1985-2013). Design/methodology/approach – The study uses monthly returns to the health care industry and overall market, characterizing each sample month as either having a Republican or Democratic president and either a contractionary or expansionary monetary policy regime determined by whether the Federal Reserve is increasing or decreasing interest rates, respectively. It incorporates univariate and multivariate analysis to quantify the return behavior of both the health care industry and the overall market during the entire period and all three sub-periods. Additionally, it utilizes a common four-factor multivariate regression model and associated hypothesis testing to characterize risk-adjusted excess returns (i.e. α) to the health care industry during the entire period and all three sub-periods. Findings – The health care industry has earned robust, positive risk-adjusted returns with the magnitude of the returns sensitive to the political party of the administration and the monetary policy regime. The authors find that prior to 1965 (1954-1964), when the president was a Republican, during times of monetary contraction, health care earned an excess risk-adjusted return. There was no association between Democratic administrations and excess health care returns prior to 1965. In contrast, the authors find that after 1965 this relationship changes. The authors find that returns to health care were positive for Republicans during times of monetary expansion and positive for Democrats during monetary contraction. The authors also find this relationship has become more pronounced after 1984. Originality/value – The study extends prior literature, which has shown that the health care industry is a priced factor in the US stock market and that it provides significant risk-adjusted returns in the recent past. Uniquely, this study shows that the excess returns to health care vary considerably over the past 60 years, and that these excess returns are quite sensitive to political policy, proxied by the presidential administration party, and monetary policy, as measured using Fed discount rate changes. These findings have implications for management and shareholders of highly regulated and subsidized industries and firms.


2008 ◽  
pp. 2770-2781
Author(s):  
Pooja Deshmukh ◽  
David Croasdell

This chapter explores privacy and security issues in health care. It describes the difference between privacy and security in the context of health care, identifies sources of concern for individuals who use information technologies for health-related purposes, and presents technology-based solutions for privacy and security in health care networks. The purpose of the chapter is to provide an investigation of the sources of concern for regulations and technologies in the health care industry. The discussion is based on the Health Insurance Portability and Accountability Act (HIPAA) and its eight guiding principles. The chapter explores the implications of legal and regulatory environments driving HIPAA regulations, the need for privacy and security in health care networks, and information technologies used in the health care industry. Related ethical issues, current technologies for providing secure solutions that comply with the regulations, and products emerging in the market are also examined.


Author(s):  
Tommasina Pianese ◽  
Patrizia Belfiore

The application of social networks in the health domain has become increasingly prevalent. They are web-based technologies which bring together a group of people and health-care providers having in common health-related interests, who share text, image, video and audio contents and interact with each other. This explains the increasing amount of attention paid to this topic by researchers who have investigated a variety of issues dealing with the specific applications in the health-care industry. The aim of this study is to systematize this fragmented body of literature, and provide a comprehensive and multi-level overview of the studies that has been carried out to date on social network uses in healthcare, taking into account the great level of diversity that characterizes this industry. To this end, we conduct a scoping review enabling to identify the major research streams, whose aggregate knowledge are discussed according to three levels of analysis that reflect the viewpoints of the major actors using social networks for health-care purposes, i.e., governments, health-care providers (including health-care organizations and professionals) and social networks’ users (including ill patients and general public). We conclude by proposing directions for future research.


1982 ◽  
Vol 8 (3) ◽  
pp. 321-348
Author(s):  
Judy B. Chase

AbstractIn National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City, the United States Supreme Court held that there is no blanket exemption from antitrust laws for health planning activities.‘The Court also held that no specific immunity can be granted where the challenged health planning activity is not undertaken pursuant to a federal regulatory scheme. This Comment reviews the Court’s decision and concludes that the Court correctly determined that the challenged activities did not qualify for an exemption. The Comment also examines the implications of the Court's statement that, where Congress has manifested a belief that competition is ineffective in the health care industry, application of the antitrust laws should be modified. The Comment recommends that an intermediate review standard such as the “presumptive, incentive modifying approach” should be used by future courts in deciding whether the ineffectiveness of competition in a given area of health planning activity warrants immunity from antitrust scrutiny.


Sign in / Sign up

Export Citation Format

Share Document